BioSpace News Archive

Biotech Beach

Ensysce Biosciences Announces Successful Meeting with FDA for PF614-MPAR, a Next Generation Opioid with Overdose Protection

Ensysce Biosciences, Inc. is providing an update following its recent meeting with the Food and Drug Administration (FDA) regarding its second product, ‘Next Generation’ opioid analgesic with overdose protection, PF614-MPAR.

February 21, 2024

·

5 min read

Business

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

Dyadic International, Inc. announced it has advanced its collaboration with the Israel Institute for Biological Research (IIBR) and its commercial arm Life Science Research Israel.

February 21, 2024

·

5 min read

Genetown

Sunbird Bio to Present Positive Data from APEX Alzheimer’s Disease Diagnostic Platform at AD/PD™ 2024

Sunbird Bio today announced that new data from a study evaluating its APEX diagnostic platform in Alzheimer’s disease will be presented at the upcoming AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Disease, taking place March 5-9, 2024 in Lisbon, Portugal.

February 21, 2024

·

2 min read

Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract

Motus GI Holdings, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent (patent # 11904085) titled, “Colon Cleaning System with Automatic Self-Purging Feature.”

February 21, 2024

·

3 min read

Drug Development

Mabwell Publishes the Phase III Study Results on Its Denosumab Biosimilar (MW032) in the journal JAMA Oncology

Mabwell recently published the phase III study results of denosumab biosimilar (MW032) online in the international top journal of JAMA Oncology.

February 21, 2024

·

5 min read

Pharm Country

Coverage Expansion Continues for One- and Two-level Lumbar Total Disc Replacement as the Top Commercial Payer in Tennessee Establishes Positive Coverage for Centinel Spine’s prodisc® L

Centinel Spine®, LLC (“the Company”) today announced significant expansion of coverage for lumbar TDR procedures in Tennessee.

February 21, 2024

·

3 min read

Drug Development

DepYmed to Meet with Investors at the BIO CEO and Investor Conference

DepYmed, Inc. (“DepYmed” or the “Company”) is a preclinical stage pharmaceutical company focused on developing transformative treatments for rare diseases and oncology that target the protein tyrosine phosphatase (PTP) family of enzymes.

February 21, 2024

·

1 min read

Drug Development

Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

Topline Results Expected in Q2 2024

February 21, 2024

·

7 min read

NervGen Pharma Recognized as a Top 50 TSX Venture Exchange Company

NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, has been recognized by the TSX Venture Exchange as a 2023 Top 50 Company.

February 21, 2024

·

5 min read

BioForest

Parse Biosciences Launches Evercode Whole Transcriptome Version 3, Boosting Usability and Performance

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced a significant update to the company’s flagship Evercode™ Whole Transcriptome products.

February 21, 2024

·

3 min read